ArticleInternational journal of cardiology. Heart & vasculature2025
Thyroid dysfunction and pulmonary arterial hypertension: A bidirectional mendelian randomization study.
Article in International journal of cardiology. Heart & vasculature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Thyroid dysfunction can cause several cardiovascular diseases. Studies have suggested a link between thyroid dysfunction and an increased risk of Pulmonary Arterial Hypertension (PAH). However, the causal association between this link is unknown. The aim of this study was to investigate the causal association between thyroid dysfunction and PAH using bidirectional two-sample Mendelian Randomization (MR) analysis. Method: Thyroid dysfunction (Free triiodothyronine (FT3), free thyroxine (FT4), thyrotropin (TSH), hyperthyroidism and hypothyroidism) and PAH were respectively used as exposure and outcome factors. The bidirectional causal association between thyroid dysfunction and PAH was analyzed by using Inverse Variance Weighting (IVW), MR-Egger regression (MR-Egger), and Weighted Median (WM) methods. Cochran's Q test was used to analyze the heterogeneity among single nucleotide polymorphisms (SNPs). The intercept term of MR-Egger regression and MR-PRESSO were used to analyze horizontal pleiotropy. The effect of single SNP on the MR analysis results was analyzed by leave-one-out method. Results: The IVW showed that hypothyroidism could increase the risk of PAH (OR = 1.485, 95 % CI [1.051, 2.100], P = 0.025), while FT3, FT4, TSH and hyperthyroidism were not associated with the risk of PAH. Furthermore, we found no evidence of reverse causal association between PAH and thyroid dysfunction. Conclusion: Our study found that hypothyroidism is causally associated with an increased risk of PAH. However, further investigations are still needed to illustrate the connection between thyroid dysfunction and PAH.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.